Interpretation and inference in noninferiority randomized controlled... (2010)

Title Interpretation and inference in noninferiority randomized controlled trials in drug research.
Published in Clinical Pharmacology & Therapeutics, Vol. 88, No. 3, p.420-. ISSN 0009-9236.
Author Wangge, G.; Klungel, O.H.; Roes, K.C.B.; de Boer, A.; Hoes, A.W.; Knol, M.J.
Date 2010
Reference(s) Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health
Language English
Type Article
Publisher Elsevier
Abstract Noninferiority (NI) trials in drug research are used for the purpose of demonstrating that a new treatment is not worse than a proven active comparator, thereby indirectly showing that the treatment is effective. This article explains and addresses the complications in the interpretation of NI trials that arise from the indirect comparison. On the basis of our review of 232 trials, we conclude that the interpretation and inference of NI trials are complicated, partly because of the incompleteness of the information.
OpenURL Search this publication in (your) library
Persistent Identifier URN:NBN:NL:UI:10-1874-196864
Metadata XML
Repository Utrecht University

Go to page top
Go back to contents
Go back to site navigation